ApoE transports amylin from blood to brain influencing brain β‐amyloid level
Human amylin forms parenchymal complexes with apoE, exacerbating Aβ pathology, especially in apoE4<sup>+</sup> mice. In the presence of non-amyloidogenic (mouse) amylin, apoE4 does not lead to Aβ or amylin accumulation. The lack of amylin and Aβ in EKO-HIP brains implicates apoE as a molecular carrier for both proteins at the blood-brain barrier. Immunoprecipitation results suggest differential strength of apoE-amylin interactions as a result of apoE isoform. Future studies investigating the specific mechanisms regulating amylin-apoE-Aβ interactions are warranted.
Authors
- Laura Radulescu
- Florin Despa (ORCID: https://orcid.org/0000-0002-5879-6449)
- Ravichandra Shivalingappa Davargaon (ORCID: https://orcid.org/0000-0001-5526-8037)
- Deepak Kotiya (ORCID: https://orcid.org/0000-0001-5794-8626)
- Noah Leibold (ORCID: https://orcid.org/0000-0001-7737-0382)
- Nirmal Verma (ORCID: https://orcid.org/0000-0002-9218-2475)
- Cate Conner
- Velmurugan Gopal Viswanathan
Institutions
- University of Kentucky (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70855_105601
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00